Invention Grant
- Patent Title: Salt and polymorphs of a DPPIV inhibitor
- Patent Title (中): DPPIV抑制剂的盐和多晶型物
-
Application No.: US11376862Application Date: 2006-03-16
-
Publication No.: US07772264B2Publication Date: 2010-08-10
- Inventor: Stefan Abrecht , Andre Gerard Bubendorf , Stephan Goetzoe , Olaf Grassmann , Francois Montavon , Regina Moog , Franziska Rohrer , Armin Ruf , Michelangelo Scalone , Urs Schwitter , Shaoning Wang
- Applicant: Stefan Abrecht , Andre Gerard Bubendorf , Stephan Goetzoe , Olaf Grassmann , Francois Montavon , Regina Moog , Franziska Rohrer , Armin Ruf , Michelangelo Scalone , Urs Schwitter , Shaoning Wang
- Applicant Address: US NJ Nutley
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Nutley
- Agent George W. Johnston; Dennis P. Tramaloni; Samuel H. Megerditchian
- Priority: EP05102251 20050322
- Main IPC: A61K31/42
- IPC: A61K31/42 ; A61K31/40 ; C07D263/34 ; C07D207/09
Abstract:
The invention is concerned with (S)-1-{[2-(5-Methyl-2-phenyl-oxazol-4-yl)-ethylamino]-acetyl}-pyrrolidine-2-carbonitrile mesylate and crystalline polymorphs of this compound. This compound and its polymorphic forms exhibits superior properties compared to the previously known compounds and can be used as medicament for the treatment of disorders which are associated with DPP-IV.
Public/Granted literature
- US20060217428A1 Salt and polymorphs of a DPPIV inhibitor Public/Granted day:2006-09-28
Information query
